Next Article in Journal
Natural Selection as the Primary Driver of Codon Usage Bias in the Mitochondrial Genomes of Three Medicago Species
Previous Article in Journal
Couple-Based Carrier Screening: How Gene and Variant Considerations Impact Outcomes
Previous Article in Special Issue
Neuromolecular Basis of Impaired Conditioned Taste Aversion Acquisition in Valproate-Induced Rat Model of Autism Spectrum Disorder
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Auditory Event-Related Potentials in Two Rat Models of Attention-Deficit Hyperactivity Disorder: Evidence of Automatic Attention Deficits in Spontaneously Hypertensive Rats but Not in Latrophilin-3 Knockout Rats

1
Department of Psychology, 202 Psychology Building, University of Memphis, Memphis, TN 38152, USA
2
Department of Behavioral Sciences and Neuroscience Program, Christian Brothers University, Memphis, TN 38104, USA
3
College of Medicine, University of Cincinnati, Cincinnati, OH 45220, USA
4
Cincinnati Children’s Research Foundation, Cincinnati, OH 45229, USA
*
Author to whom correspondence should be addressed.
Genes 2025, 16(6), 672; https://doi.org/10.3390/genes16060672
Submission received: 5 May 2025 / Revised: 26 May 2025 / Accepted: 27 May 2025 / Published: 30 May 2025
(This article belongs to the Special Issue Genetics of Neuropsychiatric Disorders)

Abstract

:
Background/Objectives: Variations of the latrophilin-3 (Lphn3) gene have been associated with attention-deficit hyperactivity disorder (ADHD). To explore the functional influence of this gene, Lphn3 knockout (KO) rats were generated and have thus far demonstrated deficits in ADHD-relevant phenotypes, including working memory, impulsivity, and hyperactivity. However, inattention remains unexplored. Methods: We assessed automatic attention in Lphn3 KO (n = 19) and their control line (wildtype/WT, n = 20) through use of the following auditory event-related potentials (ERPs): P1, N1, P2, and N2. We also extended this exploratory study by comparing these same ERPs in spontaneously hypertensive rats (SHRs, n = 16), the most commonly studied animal model of ADHD, to their control line (Wistar–Kyoto/WKY, n = 20). Electroencephalograms (EEG) were recorded using subdermal needle electrodes at frontocentral sites while freely moving rats were presented with five-tone trains (50 ms tones, 400 ms tone onset asynchronies) with varying short (1 s) and long (5 s) inter-train intervals. Peak amplitudes and latencies were analyzed using GLM-mixed ANOVAs to assess differences across genotypes (KO vs. WTs) and strains (SHRs vs. WKYs). Results: The KOs did not demonstrate any significant differences in peak amplitudes relative to the WT controls, suggesting that the null expression of Lphn3 does not result in the development of inefficiencies in automatic attention. However, the SHRs exhibited significantly reduced peak P1 (and peak-to-peak P1–N1) values relative to the WKYs. These attenuations likely reflect inefficiencies in bottom-up arousal networks that are necessary for efficient automatic processing. Conclusions: Distinct findings between these animal models likely reflect differing alterations in dopamine and noradrenaline neurotransmission that may underlie ADHD-relevant phenotypes.

1. Introduction

1.1. ADHD and Lphn3

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by hyperactivity, disinhibition, and inattention that interferes with an individual’s daily life [1]. The national prevalence of ADHD has been estimated at 11.4% in children and adolescents [2] and 6% in adults [3], with functional impairments persisting into adulthood for upwards of two-thirds of children diagnosed [4]. The Diagnostic and Statistical Manual (DSM-V-TR) recognizes three presentations of ADHD: inattentive, hyperactive/impulsive, or a combination of the two [1]. However, individuals usually present with highly heterogenous and multifaceted symptoms that may change over the course of development and do not necessarily fit within these presentations (for a review, see [5]). This complexity can make the treatment and management of symptoms difficult. Therefore, furthering our understanding of its etiology and pathophysiology may aid in better differentiating subsets of presentations and treating individuals with diverse profiles.
ADHD is highly heritable, with a reported mean heritability of 74% [6]. In addition, it is generally accepted that symptom dysfunction falls along a dimensional continuum, with those with “true” ADHD representing the extreme end of it [7,8]. This is supported by both twin and molecular studies [9]. Thus, the delineation of risk genes that contribute to the etiology and pathophysiology of ADHD may prove valuable to understanding the disorder. Variants of the latrophilin-3 (Lphn3), or adhesion G protein-coupled receptor L3 (Adgrl3), gene have been shown through genome-wide linkage [10,11,12] and association studies [12,13] to be associated with ADHD. Further, a recent meta-analysis of the most common single-nucleotide polymorphisms (SNPs) of Lphn3 reported significant associations between rs6551665 and rs2345039 SNPs and the presence of childhood ADHD [14]. Thus, understanding the functional significance of Lphn3 in ADHD may advance our knowledge of its neurobiology.
Notably, substantial genetic overlap exists with other externalizing, internalizing, and neurodevelopmental symptoms (for reviews, see [6,15]). However, this overlap is rarely addressed, in part due to the common practice of comparing groups within the conceptual bounds of DSM criteria (i.e., those with “ADHD” versus controls). Therefore, to better delineate the neurobiological underpinnings of dysfunctional phenotypes across and within different disorders, we adhere to the framework outlined by the research domain criteria (RDoC) [16,17]. RDoC shift the focus away from polythetic conceptualizations inherent in DSM-based categories to dimensional constructs that are understood to cut across psychiatric disorders (e.g., motivation, disinhibition, inattention, etc.). Furthermore, by moving from modeling complex clusters of human behavior to functional dimensions grounded in neurobiology, animal models can be generated with greater precision [18,19].

1.2. Lphn3 and Animal Models of ADHD Phenotypes

Animal models are useful for exploring the “downstream” effects of relevant genes on the neurobehavioral mechanisms that underlie mental disorders [18]. To understand the function of Lphn3, a growing number of genetic knockdown (KD; i.e., subjects that have reduced expressions of Lphn3) and knockout (KO; i.e., subjects that are null for the expression of Lphn3) models have been produced and studied, including Drosophila KDs [20], zebrafish KDs [21,22,23,24], and mouse KOs [25,26,27]. Although these models have contributed to advancing our understanding of the function of Lphn3, they lack the capacity to assess cognitive domains commonly associated with ADHD (e.g., working memory, impulsivity, learning, and memory).
To address this limitation, an Lphn3 KO rat was developed [28]. These rats have been found to be hyperactive in both novel and—unlike KO mice [27]—familiar environments [28]. Additionally, they are impulsive, demonstrate working memory inefficiencies [29,30,31], and exhibit selective deficits in egocentric and allocentric learning and memory [32]. However, despite inattention being a core characteristic of some presentations of ADHD, it has been assessed only indirectly in this model using a non-cued alteration task [31]. Thus, it remains an open question whether Lphn3 KOs exhibit deficits in attention.

1.3. Auditory-Evoked Potentials and Attention in ADHD

Event-related brain potentials (ERPs) are the summation of neural activity time locked to the presentation of a stimulus and recorded using electroencephalography (EEG) [33]. The waveform produced contains various peaks that are denoted based on their voltage polarity (“P” for positive and “N” for negative) and timing, with the latter either defined by its latency in milliseconds (e.g., P50) or the order it occurs in the waveform (e.g., P1 is the first positive peak). These peaks correspond to components that are associated with either exogenous (i.e., obligatory responses related to the characteristics of the eliciting stimulus) or endogenous (responses related to information processing and characteristic of the subject) properties, with the latter components typically having more endogenous influences [33]. Importantly, ERPs have clear genetically determined differences in humans e.g., [34], as well as rodent models of psychopathology e.g., [35], and neurodevelopment e.g., [36]. Additionally, rats exhibit relatively homologous patterns in ERP components in response to passive visual and auditory stimuli e.g., [37,38,39], to those of humans, making them a viable translational tool.
A subset of ERPs, auditory-evoked potentials (AEPs), allows for the examination of auditory processing at distinct levels of the auditory system from the cochlea to the cortex [40]. AEPs are organized into three categories based on the latency from stimulus onset: brainstem auditory-evoked potentials (BAEPs; 1–10 ms), middle latency auditory-evoked potentials (MLAEPs, 10–50 ms), and long latency auditory-evoked potentials (LLAEPs, 50–300 ms). LLAEPs are primarily measured from the scalp/dorsal cephalic position (referenced to post-auricular positions) and are colloquially referred to as ERPs. They consist of two obligatory components, the positive P1 and the negative N1, followed by alternating positive and negative peaks that reflect activity beyond primary auditory processing and are not specific to the stimulus (for a review, see [40]).
Of these components, the auditory N1 (or N100) is primarily exogenous, as it is predominantly influenced by the characteristics of the presented stimulus (e.g., intensity, saliency). However, it also has endogenous properties. Specifically, the N1 is modulated by both arousal (i.e., sensitivity to detecting environmental stimuli) and attention (i.e., allocation of cortical resources to stimuli), with a more robust N1 observed when individuals are physiologically alert and actively attending to a stimulus (for reviews, see [41,42]). In short, the N1 may function as a neural correlate of the sensory processing of an eliciting stimulus that is further modulated by one’s selective attention (i.e., top-down voluntary processes) and arousal (i.e., bottom-up automatic processes).
Given that attention may modulate the auditory N1, it is reasonable to predict that its presentation may be altered in those with ADHD; however, findings have so far been mixed. While some have reported that the N1 is generally attenuated in those with ADHD (for reviews, see [43,44]), a more recent meta-analysis reported no significant differences between ADHD and non-ADHD participants [45]. That said, these inconsistencies may be explained by several limitations, including an inability to account for several relevant moderators (e.g., specific ADHD presentation, comorbidities, symptom severity), a sole focus on males, and the fact that most of the reviewed studies feature populations that consist of children ages 6–11 years old. Additionally, this meta-analysis focused on ERPs with prominent cognitive components elicited by active tasks (e.g., selective attention, inhibitory control, and error monitoring) [45]. This is notable given that effortful attention may produce larger increases in the N1 in those with ADHD [46,47], while the N1 is reduced in the context of automatic, non-effortful attention [48].
Sable et al. [48] examined the association between automatic attention and the N1 in young adults with and without ADHD (based on self-reported diagnosis from a physician) using a passive auditory paradigm. Participants were asked to ignore auditory tone trains separated by either a short (1 s) or long (5 s) inter-train interval (ITI) while watching a silent video. As anticipated, the control group demonstrated a more robust N1 following the longer, more salient ITI; however, this difference was absent in adults with ADHD. This attenuation of the N1 was understood to reflect deficits in automatic attention in those with ADHD, with this deficit being primarily driven by a lack of bottom-up gain from subcortical structures [48].

1.4. The Current Study

To understand the influence of Lphn3 on inattention, we examined the auditory-evoked P1 and N1 and other auditory ERPs (P2 and N2) in Lphn3 KO rats compared with their wildtype (WT) control line [28]. As it is not fully understood whether the P1 or N1 is more analogous with the human N1 [49], we focused on changes in both components. To accomplish this, we utilized a modified version of the auditory paradigm previously implemented in humans to explore automatic attention [48]. This passive auditory paradigm uses trains of five tones with inter-tone intervals (onset to onset) of 400 ms, each separated by either a 1 s (short) or 5 s (long) ITI. By varying the period of silence between each train, it is possible to examine both the attenuation of AEPs across tones (i.e., a reduction in response across repeated tones in train) and the recovery of the response (i.e., a greater response following the 5 s ITI than 1 s ITI), which can take as long as ~5 s in rats [50]. Therefore, this paradigm allows for the examination of not only the absolute P1 and N1 amplitudes, respectively, but also the interaction between attenuation (i.e., inhibition) and recovery (i.e., release from inhibition; see [51] for supporting information on the distinction between these processes).
We also assessed these auditory ERPs in a more established animal model of ADHD, the spontaneously hypertensive rat (SHR). The SHR line was created by selectively breeding Wistar–Kyoto (WKY) rats from disparate lines for high cytosolic blood pressure [52]. SHRs have demonstrated good face validity, with evidence of hyperactivity, impulsivity, and inattention (for a recent review, see [53]). Notably, however, only sustained attention has been evaluated in this model [54,55]. While a single study was found that noted altered sensory gating based on ERP changes in SHRs [56], automatic attention processes have remained broadly unexplored.
In summary, we aimed to determine whether Lphn3 KO and SHRs demonstrate deficits in automatic attention, as indicated by reductions in P1 and/or N1 amplitudes to the first tone following the 5 s ITI. By doing this, we sought to determine whether the null expression of Lphn3 produces deficits in automatic attention, while adding to the construct validity of the SHRs.

2. Materials and Methods

2.1. Animals

All procedures were sanctioned by The University of Memphis Institutional Animal Care and Use Committee (IACUC; protocol #0864) and conducted in accordance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals [57]. A total of 21 SHRs (9 F and 12 M) and 24 WKYs (12 F and 12 M) were obtained from Charles River Laboratories (Kingston, NY, USA) and arrived at the University of Memphis at approximately postnatal day (P) 45. A total of 22 Lphn3 KOs (11 M and 11 F) and 24 WTs (14 F and 10 M) from a Sprague–Dawley background (SD-IGS, strain 001, Charles River Laboratories, Charleston, NC, USA) were acquired from the Cincinnati Children’s Research Foundation at approximately P30. The KOs were generated at the Cincinnati Children’s Transgenic Animal and Genome Editing Core utilizing CRISPR/Cas9 to delete exon 3 (see [28] for details regarding this process and the confirmation of the successful deletion of Lphn3). One rat per genotype per sex per litter was randomly selected for this experiment with the use of a random number table.
Upon delivery, same-sex and same-strain rats were pair-housed in standard plastic cages (45 cm × 24 cm × 30 cm) with corn cob bedding. They were then housed in a room with controlled temperature (23 ± 2 °C) and humidity (30–70%) and a 12 h reverse light/dark cycle (lights off at 0700 h). Rats had ad lib access to feed (Teklad 2018, Lafayette, IN, USA) and water until P60, at which time they were placed on a food restriction schedule and maintained at 85–90% of free-feeding weight, which was adjusted bi-weekly to account for any growth. Behavioral testing began at P70 (see [31] for details). At the conclusion of behavioral testing, rats remained pair-housed and were transitioned to free feed for the duration of this study. The average postnatal (P) age of the KO rats was P182.33 (SD = 19.79) and the average P age of the WTs was P182.25 (SD = 22.79) at the time of EEG data acquisition, while that of the SHRs was P196.32 (SD = 5.24) and that of the WKYs was P195.63 (SD = 5.36).

2.2. Electrode Placement

ERPs were recorded in awake rats via a method we adopted for use in both awake and anesthetized rats [58]. Each rat was initially placed in an induction box and anesthetized with 3–4% isoflurane in oxygen until sedated, as confirmed by the absence of tail and toe (pedal) pinch reflexes. They were then transported to the operating table and placed on an electric heating pad, where anesthesia depth was maintained using 1–2% isoflurane in oxygen via a nose cone. The fur from the scalp to the base of the neck was shaved using an electric razor, and any remaining stubble was removed using a depilatory of potassium thioglycolate. The exposed skin was thoroughly rinsed with water and soaked gauze, swabbed with betadine, and cleaned with a 70% isopropyl alcohol pad.
Three 7 mm disposable subdermal needle electrodes (Rhythmlink; Columbia, SC, USA) were inserted into the scalp. The recording electrode was placed ~3 mm anterior to the bregma, terminating directly above the frontal cortical region (roughly homologous to Fz in humans). The reference electrode was caudal to the right ear, while the ground was symmetrically placed caudal to the left ear. Impedance was checked using Biopac MP36 and BSL software version 4 (Biopac System Inc.; Goleta, CA, USA), with values below 15 kΩ considered acceptable. An initial administration of cyanoacrylate adhesive (i.e., super glue) was used to secure the electrodes and then supplemented by a generous application of Collodion-soaked gauze. Tegaderm HP (3M; St. Paul, MN, USA) transparent dressing was then placed over the electrodes once the collodion had dried. The rat was then outfitted with a jacket (Instech Laboratories Incorporated; Plymouth Meeting, PA, USA) connected to a flexible stainless steel spring to cover and secure the lead wire. Once the jacket was confirmed to be secured, but not excessively tight such that it impeded movement or caused discomfort, the isoflurane flow was discontinued so that the rat was only receiving pure oxygen through the nose cone. After the rat voluntarily removed its nose from the nose cone, it was placed in a recovery chamber for an additional 30 min. Once fully recovered, it was moved to a 50 cm × 50 cm × 25 cm sound-attenuated chamber for ERP recordings. This entire process took approximately 35 to 40 min to complete for each rat.

2.3. ERP Recordings and Auditory Stimuli

Once the rat was in the testing chamber, the lead wires were fed through the top and connected to a swivel to permit the rat to freely move throughout the chamber. Each rat was given ~5 min to acclimate to the chamber prior to EEG acquisition. The lead wires were connected to an integrated ERP recording system utilizing a Biopac MP36 and BSL software (Biopac System Inc.; Goleta, CA, USA). EEG data were sampled at 500 Hz with a DC to 100 Hz band pass filter and a 60 Hz notch filter. Data were further filtered offline using an FIR filter with a 0.01–30 Hz bandpass (for further information regarding data collection setup, see [58]).
Following 2 min of recording resting EEG data, the rat was presented with a series of tone trains, each preceded in randomized order by either a 1 or 5 s ITI, for a total of 320 trains/ITIs (160 long and 160 short). The trains consisted of ~90 dB complex tones with a 500 Hz fundamental frequency and harmonics at 1000 and 1500 Hz (−3 dB and −6 dB, respectively, relative to the fundamental). All tones were 50 ms in duration, with 5 ms Gaussian onset and offset periods and 400 ms stimulus onset asynchronies (SOAs) within tone trains (see Figure 1). The tones were calibrated prior to each recording session using an ambient sound meter. Tone trains played through a speaker centered near the top of the back of the testing chamber and were presented using SuperLab version 4.5 (Cedrus Corp., San Pedro, CA, USA). The onset of each ITI was recorded and marked in the EEG data file using a StimTracker (Cedrus, San Pedro, CA, USA).
Rats with ≥60 accepted trials were considered to have a valid number of trials to be included in the analyses. KOs had an average of 121 short and long accepted ITI trials (minimum short and long ITI values were 90 and 91, respectively), and WTs had an average number of 125 short and 126 long accepted ITI trials (minimum of 74 and 76 long and short ITI trials, respectively). No significant difference was found in the number of accepted trials between KOs and WTs for short ITIs [t (37) = −0.515, p = 0.609] or long ITIs [t (37) = −0.670, p = 0.507]. SHRs demonstrated a significantly greater number of rejected trials than WKYs for both short [t (34) = −8.537, p < 0.001] and long ITIs [t (34) = −7.764, p < 0.001]. This was predominantly related to a high number of movement artifacts observed in SHRs, likely due to their more hyperactive nature. Given this, a select number of SHRs completed ~1–3 additional recording sessions to obtain a sufficient number of usable trials. This process was also performed with the remaining WKYs to maintain consistency across both strains. For each rat, two sessions were selected to maximize the number of usable trials after a visual inspection of the quality of the waveforms. Weighted averages were then calculated from the selected sessions. SHRs had a combined weighted (n = 18) and non-weighted (n = 3) average of 91 short and 93 long accepted ITI trials (a minimum of 55 long and 62 short ITIs), and WKYs had a combined weighted (n = 14) and non-weighted (n = 10) average of 136 for both short and long accepted ITI trials (a minimum of 95 long and 94 short ITI).

2.4. EEG Processing and ERP Analyses

A custom MATLAB (version 9.11) script was used to generate ERPs. The EEG was separated into epochs consisting of 200 ms before to 2000 ms after tone train onset, with the 200 ms pre-stimulus baseline mean subtracted from each point in the epoch. Epochs with voltage peaks exceeding ±100 μVs were excluded from further analyses, while remaining epochs were averaged separately for each genotype/strain (KO, WT, SHR, and WKY) and ITI (1 s and 5 s). This process generated an average ERP waveform for each genotype and strain based on the average response across all tone trains for the 1 s and 5 s ITIs. ERP peaks were identified based on a visual inspection of the grand average ERP waveform for the 5 s ITI across control lines (based on the assumption that the responses to the first tone would be largest under this condition), as well as from previous conventions in rodents and humans (e.g., [38,39]). The following ERP peaks were defined: the most positive point from 0 to 100 ms for P1, the most negative point from 50 to 150 ms for N1, the most positive point from 100 to 300 ms for P2, and the most negative point from 200 to 350 ms for N2. The latency range used was wider than previous conventions to better capture each ERP peak across rats, as peaks were more delayed in response to the tone trains than what we observed for tone pairs [58].
Prior to analysis, individual subjects that were judged to have a poor signal quality based on a visual inspection or an insufficient number of usable trials (≤60) were removed. This resulted in the exclusion of 3 KOs (2 males and 1 female), 4 WTs (4 females), 4 SHRs (2 males and 2 females), and 3 WKYs (1 male and 2 females). Following this process, outliers were assessed for peak amplitudes and latencies. Rats with significant outliers (i.e., ±3 SD) across several ERP components and multiple variables were removed, as these outliers were deemed too extreme to be addressed through mean imputation. This resulted in the removal of a 1 additional male SHR and WKY, leaving 19 KO rats (9 males and 10 females), 20 WT rats (10 females and 10 males), 16 SHRs (7 females and 9 males), and 20 WKY rats (10 females and 10 males). Due to the high number of variables, any remaining outliers with 1–2 measures were retained and adjusted using 2 SD imputation with matched between-subject variables (i.e., genotype/strain and sex). This process was performed to maximize power by limiting the removal of rats that contained outliers on a few select measures for one component, while addressing the remaining outliers through mean imputation to reduce their influence on the parametric analyses. Based on a prior power analysis using G*Power version 3.1.9.7 [59], we determined we had adequate samples of KOs/WTs (N = 39) and SHRS/WKYs (N = 36) to detect medium effects (f = 0.25) for mixed GLM ANOVAs, given a significance criterion of α = 0.05 and power = 0.80.
Average peak amplitudes and latencies were analyzed for P1, N1, P2, and N2. Special attention was given to the P1 and N1 peaks, since it is unclear which component is homologous to the human N1 [49], and these components have been observed to most significantly reflect physiological changes in response to a similar tone pair paradigm [58]. Peak amplitudes and latencies were analyzed using two separate 2 (genotype or strain) × 2 (sex: male/female) × 2 (ITI: 1 s/5 s) × 5 (tone: 1–5) mixed GLM ANOVAs for KOs and SHRs, respectively, and their respective control lines (i.e., WTs and WKYs). In addition, peak-to-peak amplitudes were analyzed, as the latter provides an alternative measure of peak amplitude that is not confounded by residual noise or artifacts contained in the pre-stimulus baseline [33]. Peak-to-peak measures were calculated by subtracting the first peak amplitude (e.g., P1) from the second adjacent peak (e.g., N1) and recording the absolute value. This generated three peak-to-peak measures: P1–N1, N1–P2, and P2–N2. Significant or approaching omnibus findings (p ≤ 0.05) were followed up using simple pairwise comparisons with Bonferroni adjustments to determine the nature of the significant interactions across various conditions. A Greenhouse–Geisser correction was used for omnibus findings when appropriate to account for violations of sphericity. All analyses were conducted using SPSS version 27.0 (IBM Corp; Armonk, NY, USA).
Given that no clear sex differences emerged, and for the sake of brevity, we have opted to limit the reported results to peak amplitudes and latencies collapsed across sex [see Appendix A for significant peak-to-peak and sex statistical findings and the Supplementary Materials for inferential statistics on Lphn3 KO versus WT (Supplementary Tables S1–S7) and on SHRs versus WKYs (Supplementary Tables S8–S14)].

3. Results

3.1. Lphn3 KO Rats

Grand average waveforms for KOs and WTs are shown in Figure 2. Separate waveforms are presented for each genotype and ITI collapsed across sex. The waveform demonstrated the anticipated pattern of a larger response to the initial tones of the trains, with this response being most prominent following the longer ITI. This pattern resembled those found when a similar tone pair paradigm was used in awake Wistar rats [58], as well as what has been previously demonstrated in humans using this paradigm e.g., [48,60,61]. However, the P2 and the N2 were notably not as robust, with both being almost absent following the shorter ITI.

Peak Amplitudes and Latencies in KOs Versus WTs

All peak amplitude and latency inferential statics for KOs and WTs are provided in Supplementary Tables S1–S7. The peak amplitudes for each ERP component, collapsed across sex, are depicted in Figure 3. The P1 amplitude (shown in Figure 3A) was substantially greater following the first tone compared to the second tone [main effect of tone, F (2.64, 92.25) = 35.48, p < 0.001, η p 2 = 0.198). The P1 was larger for the first tone following the 5 s ITI compared to the 1 s ITI (a 3.10 µV difference), as well as for the second tone (a 2.14 µV difference; ITI x tone, F (3.069, 107.405) = 18.372, p < 0.001, η p 2 = 0.344). No effects of genotype on P1 peak amplitude were found. For peak latency, the P1 peaked earlier following the 5 s ITI (52. 48 ± 2.35 ms) compared to the 1 s ITI (60.73 ± 2.68 ms; ITI, F (1, 35) = 14.956, p < 0.001, η p 2 = 0.299), but no significant effects of genotype were seen.
The N1 amplitudes are shown in Figure 3B. Like the P1, the N1 was largest for the first tone, followed by a significant decrease across subsequent tones in the train, with this decrease being more prominent following the longer ITI. The N1 was greater for the first tone when it was followed by the 5 s ITI (−11.87 ± 1.06 µV) compared to the 1 s ITI (−5.43 ± 0.66 µV), with this effect persisting to the second tone in the train (−2.98 µV difference; ITI x tone, F (1.976, 69.165) = 26.924, p < 0.001, η p 2 = 0.435). However, no genotype differences were seen in the N1 peak amplitude. Analysis of N1 peak latency revealed a significant sex x tone interaction (Supplemental Table S2), but no effects of genotype or ITI emerged.
The P2 amplitudes (see Figure 3C) to the initial tone were less robust than for N1 amplitudes and did not return to baseline (refer to Figure 3B), which resulted in negative values to the first and second tones. The P2 was larger for the first tone following the 5 s ITI compared to the 1 s ITI in both KOs (−4.66 ± 1.08 µV vs. −0.82 ± 0.76 µV) and WTs (−2.70 ± 1.05 µV vs. −0.42 ± 0.73 µV), with this effect persisting to the second tone only in the WTs (−1.53 µV difference). In addition, the P2 significantly decreased from the first tone to the second tone only after the 5 s ITI in KOs (3.09 µV difference) and not the WTs [genotype x ITI x tone, F (2.486, 87.013) = 3.919, p < 0.016, η p 2 = 0.101]. The P2 generally peaked earlier following the 1 s ITI (182.90 ± 9.09 ms) compared to the 5 s ITI (200.99 ± 8.01 ms; main effect of ITI, F (1, 35) = 10.958, p = 0.002, η p 2 = 0.283). It also peaked earliest for the first tone of the train (175.44 ± 9.30 ms), which was significantly earlier than the second tone (35.10 ms difference; main effect of tone, F (1, 35) = 3.635, p = 0.008, η p 2 = 0.094), No genotype-related differences were seen in P2 latency.
Like the P1 and N1 amplitudes, the N2 amplitudes (shown in Figure 3D) were larger for the first and second tones following the 5 s ITI (−8.79 ± 1.04 µV and −5.351 ± 0.59 µV) compared to the 1 s ITI (−5.79 ± 0.56 µV and −3.89 ± 0.43 µV), followed by a decrease in amplitude across subsequent tones, particularly after the 5 s ITI [ITI x tone, F (2.464, 86.234) = 14.131, p < 0.001, = 0.288]. In addition, when collapsed across ITIs, the N2 significantly decreased from the first to the second tone in KOs (−3.46 µV difference; genotype x tone, F (1.590, 55.662) = 3.538, p = 0.046, η p 2 = 0.092), while this reduction was absent in WTs. However, the difference between KOs and WTs in N2 amplitude for the first tone did not reach the criterion for significance (p = 0.054). For N2 peak latency, while a significant main effect of tone was found [F (4, 140) = 3.411, p = 0.011, η p 2 = 0.092], no differences between tones in the train were detected following pairwise comparisons (p > 0.05). Likewise, no genotype differences or other notable effects emerged for N2 peak latency.

3.2. Spontaneously Hypertensive Rats

Grand average waveforms for the SHRs and WKYs, for each strain and ITI, are shown in Figure 4. The waveform for the WKY controls demonstrated a similar pattern as those for the KOs and WTs, with a clear P1 and N1 and less robust P2 and N2. Notably, however, the P1 and N1 were substantially attenuated in the SHRs, with these rats also having a more pronounced N2.

Peak Amplitudes and Latencies in SHRs Versus WKYs

All peak amplitude and latency inferential statics for SHRs and WKYs are provided in Supplementary Tables S8–S14. The peak amplitudes for each individual ERP component, collapsed across sex, are depicted in Figure 5. The P1 amplitudes are shown in Figure 5A. The P1 for the first tone in the train was significantly smaller in the SHRs than in the WKYs, with this reduction being prominent following the 5 s ITI (4.57 µV difference; strain x ITI x tone, F (2.824, 90.382) = 2.996, p = 0.038, η p 2 = 0.086). For peak latency, the P1 peaked earliest for the first tone of the train (50.56 ± 2.89 ms) relative to the second (17.19 ms difference) and third tones (11.66 ms difference; main effect of tone, F (4, 128) = 5.365, p < 0.001, η p 2 = 0.144); however, no difference in strain was detected.
The N1 amplitudes are shown in Figure 5B. The N1 was larger for the first tone following the 5 s ITI (−4.20 ± 0.61 µV) compared to the 1 s ITI (−1.94 ± 0.41 µV) in the WKYs, while this difference was absent in SHRs (−0.05 µV difference; strain x ITI x tone interaction, F (3.052, 97.670) = 3.591, p = 0.016, η p 2 = 0.101)). In addition, the N1 was larger for the fifth tone following the 1 s ITI in the SHRs than in the WKYs (−2.91 ± 0.56 µV vs. −1.94 ± 0.42, respectively). Regarding peak latency, the N1 peaked significantly later for the first tone (116.20 ± 4.58 ms) compared to the third (84.27 ± 5.95 ms), fourth (89.43 ± 4.49 ms), and fifth tones (88.71 ± 4.10 ms), but not the second tone (94.38 ± 5.95 ms; main effect of tone, F (4, 128) = 9.856, p < 0.001, η p 2 = 0.235). Furthermore, the N1 peaked earlier in the WKYs (87.19 ± 4.07 ms) than in the SHRs (101.99 ± 4.55 ms; main effect of strain, F (1, 32) = 5.868, p = 0.021, η p 2 = 0.155).
The P2 amplitudes are shown in Figure 5C. The P2 was not as robust as the prior N1 peak for both WKYs and SHRs (refer to Figure 5B). This appears to be due to the temporal overlap of the N1 and P2 components (i.e., a larger N1 following the first tone and signal regression to the mean), which appeared to be driven predominantly by females across strains (refer to Appendix A.4). No effects of strain were detected on P2 amplitude. For P2 latency, it peaked earlier for the first tone (129.61 ± 4.13 ms) compared to any subsequent tones in the train (main effect of tone, F (3.115, 99.669) = 7.005, p < 0.001, η p 2 = 0.180). No other effects were found for P2 peak latency.
The N2 amplitudes are shown in Figure 5D. The N2 was greater for the first tone followed by the 5 s ITI (−6.73 ± 0.48 µV) compared to the 1 s ITI (−5.16 ± 0.33 µV), and it was attenuated across subsequent tones (ITI x tone, F (2.252, 72.076) = 7.710, p < 0.001, η p 2 = 0.194). Notably, the N2 was larger in the SHRs than it was in the WKYs for the first (−3.19 µV difference), second (−2.03 µV difference), third (−2.11 µV difference), and fifth tones (−1.69 µV difference; strain x tone, F (2.694, 86.195) = 4.551, p = 0.006, η p 2 = 0.127). The N2 peak latency for the first tone occurred earlier when it was preceded by the 5 s ITI (255.70. ± 6.21 ms) compared to the 1 s ITI (281.61 ± 8.2 ms; ITI x tone, F (3.440, 110.073) = 2.689, p = 0.034, η p 2 = 0.078), but no significant effect of strain was detected.

4. Discussion

The overall ERP waveform demonstrated the anticipated pattern. Excluding the SHRs, the first tone of the tone train following the 5 s ITI elicited a robust P1–N1 complex, followed by the attenuation of responses to the subsequent tones across KO, WT (see Figure 2), and WKY rats (see Figure 4). Several processes may explain this: (1) the greater salience of the first tone of the train following the longer ITI elicited greater neural activation of perceptual and attentional networks, (2) latent inhibition from frontal inhibitory networks reduced subsequent responses in the train [61], or (3) a combination of these two processes.
Additionally, differential effects were seen across these two rat models. While no meaningful effect of genotype was observed for any of the assessed ERPs between the Lphn3 KOs and their WT controls, the SHRs exhibited a very clear attenuation of P1 (see Figure 5A) and P1–N1 (see Figure A1 and Figure A2) relative to the WKYs.). Furthermore, the N2 was more pronounced in the SHRs than the WKY rats. While source localization could not be delineated given the use of a single channel, this suggests that inputs from more cortical areas increased as the signal propagated from subcortical to cortical areas, which may function as a compensatory mechanism in SHRs. Together, these differences in ERP peaks suggest that SHRs exhibit deficits in automatic attention, whereas Lphn3 KOs do not. This likely reflects differences in the underlying neurobiology of the attentional networks in these two rat models.

4.1. SHRs and the Locus Coeruleus

Attention encompasses a range of neural networks that engage both sensory and cognitive processes. One theory proposed by Posner and Petersen [62,63], divides attention into three relatively distinct networks: (1) alerting (acquiring and maintaining a level of tonic arousal needed for sustaining vigilance), (2) orientating (prioritizing and directing attention to sensory stimuli), and (3) executive functioning/focal attention (e.g., top-down control of sensory stimuli). Within this framework, attentional issues in ADHD have been suggested to result from dysfunction in both the executive and alerting networks [64]. Automatic attention is under the influence of both the frontal cortical (executive) and subcortical (alerting) networks, with the former functioning to inhibit irrelevant stimuli and the latter sustaining optimal arousal/alertness to detect salience and changes in the environment [65].
It has been suggested that N1 attenuation to repeated stimuli in humans is a consequence of top-down inhibitory mechanisms that exert habituating effects on increasingly irrelevant sensory stimuli [61]. This is supported by the reduced N1 attenuation in older adults, given that decreased activity in these frontal inhibitory networks occurs with aging [60]. However, the reduced amplitude of the P1/P1–N1 in the SHRs was primarily driven by a substantial attenuation to the first tone of the tone train, particularly after the 5 s ITI. This suggests that inefficiencies in bottom-up subcortical arousal networks, rather than in frontal top-down inhibitory networks account for this reduction in N1 amplitude. This pattern is similar to what was observed in young adults with ADHD using a similar version of this paradigm [48].
Halperin and Schulz [66] proposed that ADHD is a condition that reflects dysfunction in relatively developmentally static subcortical structures, with the maturation of the prefrontal cortex and white matter tracts leading to reductions in ADHD symptoms with age [4]. This proposal implicates several systems and regions, possibly including the basal ganglia/midbrain dopamine (DA) system, the hindbrain norepinephrine (NE) system, and the cerebellum [66]. Of these, the NE system originating from the locus coeruleus (LC) is a likely candidate for underlying the attenuation of the P1 and P1–N1 complex in the SHRs.
The LC, as well as sub-coeruleus α1 and α2 brain stem nuclei, serve as the primary neural substrates of NE [67,68]. Although the LC-NE system has been implicated across an array of cognitive processes (for reviews, [65,69,70,71,72]), one function it serves is the maintenance of an organism’s level of arousal (i.e., the ability to receive information) and activation (i.e., the ability to react to information) to effectively respond to a given stimulus [73]. This occurs through two broad processes: (1) longer, slower tonic shifts that function to adjust or maintain a level of arousal best suited for responding to a particular context, such as during sleep versus scanning for threats [67], and (2) shorter, faster phasic firing in response to a stimulus, particularly task- or goal-related stimuli [73], with salient stimuli eliciting a more pronounced phasic response [74]. For most individuals, tonic firing can efficiently adjust to address the need for focused or flexible attention, while these dynamic shifts may be impaired in those with ADHD or ADHD symptoms [75].
Aboitiz et al. [76] proposed that an imbalance in tonic catecholaminergic signaling, particularly DA and NE, leads the attentional network in those with ADHD to be less effective at adjusting to meet environmental demands. Specifically, dysfunctions in these tonic shifts are believed to contribute to dysregulated phasic activation, with supra-optimal tonic levels leading to a poorer “signal-noise ratio” for salient information and bursts of impulsive responding and super-optimal levels leading to oversensitive phasic threshold activation and distractibility. This proposal aligns with the cognitive–energetic model of ADHD, which views ADHD as stemming from a deficit of response readiness and inhibition due to impairments in these energetic pools from bottom-up subcortical areas [77,78] (also, see [79] for an introduction to the cognitive–energetic model).
SHRs have higher concentrations of NE in both the prefrontal cortex and LC [80,81], as well as hypernoradrenergic and hypodopaminergic activity in the prefrontal cortex (PFC) compared with controls [81]. Additionally, unlike Wistar rats, functional α1 adrenergic receptors involved in increasing the release of NE remain active in the LC neurons of SHRs throughout development, which may weaken α2 signaling and impair LC function [82]. These findings jointly suggest that SHRs possess an imbalance in DA and NE similar to that seen in some individuals with ADHD. This implies that SHRs have inefficient tonic and phasic LC activation, a notion supported by evidence that the sensory gating of auditory ERPs is selectively influenced by arousal in frontal and parietal areas in the rat brain [83], with high [84] and low tonic levels contributing to the attenuation of these ERPs [85]. In addition, the increased N2 in SHRs may reflect a compensatory mechanism in cortical activation to compensate for this reduced bottom-up input due to the imbalance in LC signaling, but this idea requires further investigation.

4.2. Lphn3 KOs and Dopamine Dysfunction

Lphn3 KO rats exhibited similar ERP peaks as their WT counterparts (Figure 2). This appears to reflect the preservation of automatic attention and, possibly, the alerting attentional network in this model, unlike in the SHRs. Subsequently, this null finding in the context of the noted deficits in other ADHD-relevant behaviors [27,28,29,30,31] suggests relevant differences in neurobiology between these two ADHD animal models.
LPHN3 is predominantly expressed in the brain [86,87], with the highest levels found in the PFC, caudate nucleus, amygdala, and cerebellum [11]. It is believed to play a role in synaptogenesis and synaptic connectivity [88,89,90], and its expression decreases throughout development [11]. Lphn3 KO rats exhibited no differences in the levels of DA, NE, serotonin, or other major metabolites in the striatum, hippocampus, or PFC compared with WT rats. However, tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase were elevated. This was understood to indicate a higher availability of DA and/or NE in the striatum [28]. Additionally, KOs exhibited increased striatal DA transporter (DAT) density [28], as well as saturated phasic DA neurotransmission in the neostriatum (caudate–putamen; [91]) relative to WTs, which was suggested to partially account for the downregulation of D1 receptors [28]. More recently, Sable et al. [92] reported somewhat discrepant findings, with KOs exhibiting reduced sum phasic DA release and DAT in the nucleus accumbens (NAcc) core and medial prefrontal cortex (mPFC). However, while these differences may be related to methodology, it is also possible that the null expression of Lphn3 produced differential changes in two separate pathways. Specifically, it is possible that Lphn3 KO rats possess hyperdopaminergic signaling in the dorsal stream related to stimulus response [91] and hypodopaminergic signaling in the NAcc-mPFC ventral stream associated with motivation and goal-directed behavior [92].
These alterations in DA signaling pathways provide support for the behavioral phenotypes of KO rats. Specifically, increased transient DA release in the neostriatum may contribute to KO rats’ hyperactive behavior, while phasic decreases in DA in the NAcc [92] may underlie their deficit in impulsive action relative to WTs [30,31]. Similarly, it is likely that differences in the mesocorticolimbic pathways between Lphn3 KOs and SHRs can explain the present null ERP findings between KO and WT rats relative to the profound differences seen for SHRs. For instance, the lower NAcc-to-mPFC DA ratio observed in SHRs relative to WKYs implies that SHRs have more pronounced deficits in coherence between the mesolimbic and mesocortical pathways than KOs when compared with their WT counterparts [92]. These differences are further reflected by the presence of inefficiencies in impulsive choice in SHRs but not KOs [29]. Although it is currently unclear whether a DA/NE imbalance is present or at least functionally similar in Lphn3 KOs relative to SHRs, these differences in DA signaling and the present findings appear to implicate differences in the disruption of the mesocorticolimbic pathways between these models. We suggest that tonic catecholaminergic signaling, at least in the alerting network, is likely relatively spared in Lphn3 KOs versus SHRs.

4.3. Considerations and Limits

Although the present findings are promising, some factors merit consideration during interpretation. First, it is worth noting that the Lphn3 KO rat reflects the null expression of Lphn3; therefore, it does not provide a direct model of the risk variants of Lphn3 found in humans with ADHD [11]. However, the Lphn3 KO rat still provides insights into relevant neurobiological systems that may be implicated (or, in the case of our findings, not implicated) in individuals with risk variants of the gene that could not be explored otherwise.
Second, although the SHR is a well-validated and -supported animal model for examining ADHD-relevant phenotypes, it has limitations. One concern is that SHRs are, foremost, a model of hypertension. Hypertension typically emerges in SHRs as early as 10 weeks [52] and remains stable at 7 months [93]. This can be problematic for auditory studies, given that hypertension can exacerbate age-related hearing loss [94,95], with changes occurring as early as 3 months [93]. This raises validity concerns, as it could be argued that the reductions in auditory ERPs observed in the SHRs reflect reduced inputs from the auditory cortex due to cumulative cochlear damage [95]. Although we did not directly assess hearing loss, the likelihood that the results simply reflect a loss of hearing is unlikely given several factors. First, researchers have found that the rat dorsal-recorded ERPs receive contributions from both the medial and subcortical structures and are not entirely dependent on the auditory cortex [96]. Second, the intensity of the tones used in the experiment was great enough to likely compensate for any loss of hearing based on reported auditory thresholds in this model [93]. Finally, the results are based on the interactions among ERP amplitudes, not on simple main effects between the groups. These considerations help affirm that our findings represent true neurobiological effects that are not confounded by hearing loss. Even so, it is important to remain mindful of and guard against the potential untoward effects of hypertension when investigating this model.
Third, given the hyperactive nature of the SHRs, adjustments had to be made to ensure that an adequate number of trials were obtained to generate reliable ERPs. Our decision to use weighted averaging may have contributed to some artificial reductions in the waveform due to regression to the mean. However, weighted averages were also used to generate ERPs for the majority of WKYs. In addition, the attenuation of the P1 and P1–N1 in the SHRs was so pronounced that it seems unlikely that it simply reflects an artifact from post-processing. While the use of anesthetized versus awake rats may have addressed the issue of movement artifacts, low levels of anesthesia can have a profound effect on auditory-evoked activity from the cortex and lower brain areas [96], with general anesthesia producing a substantial decrease in these ERPs [58]. In the future, SHRs may benefit from extended time to habituate to the testing chamber, as we observed reduced locomotor activity and a greater number of accepted trials for subsequent recordings.
Lastly, it should be noted we used a less typical, semi-invasive EEG acquisition method, with subdermal needle electrodes. A more invasive method, such as epidural screw electrodes, could have provided improved signal quality relative to that provided by the subdermal needle electrodes used. However, our prior work with these subdermal needle electrodes demonstrated that they can be used to acquire valid auditory ERP peaks from awake rats [58]. This less invasive method is important, as it strikes a balance between minimizing harm to the rat and producing reliable data, in accordance with the “Three R’s” of animal research [97].

4.4. Clinical Implications and Future Research

The current findings of an attenuated P1/P1–N1 in SHRs and not Lphn3 KOs, which reflects relevant differences in underlying brain mechanisms, have implications regarding the development of ADHD medications. At present, stimulants, including methylphenidate (MPH), amphetamine (AMP), and dextroamphetamine (D-AMPH), are the current first-line medications for the treatment of ADHD, while a nonstimulant (e.g., atomoxetine) may function as alternative [98]. Broadly, these drugs increase extracellular catecholamine concentrations, particularly DA and NE; however, their methods of modulating DA and NE levels differ mechanistically based on the relative density of DAT and norepinephrine transporter (NET) in different regions of the brain in conjunction with the levels of affinity of DA and NE for these transporters [99]. Therefore, the beneficial effects of these drugs (i.e., the relief of ADHD symptoms) could be dependent on the underlying brain mechanisms. By having a clearer understanding of these brain differences in relation to a medication’s mechanism and regional specificity on ADHD phenotypes, clinicians could more effectively individualize medication regimens.
The use of these auditory ERPs could provide an index to explore the influence of different stimulants and nonstimulants on automatic attention in rat models of ADHD phenotypes. In SHRs, MPH has been shown to improve some aspects of impulsivity and attention, but not hyperactivity [100], while atomoxetine had null effects on impulsive action [101] or choice [102]. As noted, SHRs and Lphn3 KOs exhibit divergent disruptions in the mesocorticolimbic pathways, which is reflected by the reduced P1/P1–N1 in the SHRs and not the KOs. We have suggested that medications that either selectively decrease DE and NE in mPFC or increase DA and NE in the NAcc may be most effective at addressing the phasic DA disbalance in SHRs [92]. Testing this hypothesis by assessing whether the P1/P1–N1 is normalized in medically treated SHRs presents a unique opportunity to further characterize the brain mechanisms that underlie automatic attention (i.e., arousal) in this model.
Beyond this, our findings highlight the translational value of these auditory ERPs as clinical tools for bridging preclinical and human research. The pattern elicited by these tone trains was similar to that observed in human controls using this paradigm [48,60], which suggests that the neurophysiological mechanisms are being activated in a similar manner in both humans and rats. In addition, the P1/P1–N1 attenuation seen in the SHRs approximated that observed in young adult humans with ADHD [48]. These homologous qualities support the use of these ERPs as an index of automatic attention across species. Additionally, this means that they could be used to study the influence of different medications in rats and human participants alike. Future research may expand on these findings in human studies of ADHD to assess the degree to which different stimulant and nonstimulant medications modulate the amplitude of these ERPs, as well as how different ADHD profiles influence these effects, or lack thereof, based on neuropsychiatric factors.

5. Conclusions

The purpose of this study was to determine whether two animal models of ADHD, the Lphn3 KO rat and the SHR, demonstrate deficits in automatic attention as indexed by alterations in auditory ERPs, particularly the P1 and N1. SHRs exhibited significantly reduced P1s and P1–N1 complexes relative to WKYs in response to tone trains, indicating deficits in automatic attention. The attenuation of the ERPs was primarily driven by the reduced P1/P1–N1 for the first tone of the train, especially following a longer interval. This reduction implicates the inadequate amplification of the subcortical inputs that comprise the alerting network rather than insufficient top-down inhibition. In contrast, we found no evidence of inefficiencies in automatic attention in Lphn3 KO rats, with KOs demonstrating similar P1 and N1 peaks relative to WTs. This suggests the preservation of subcortical inputs involved in the alerting network and possibly less disrupted tonic DA and NE signaling in Lphn3 KO rats than in SHRs. Overall, our findings suggest that Lphn3 does not contribute to deficits in automatic attention and provide further evidence related to the important distinctions between SHRs and Lphn3 KOs in the mesocorticolimbic pathways.
In the context of the existing behavioral profile of SHRs, the present findings suggest that this rat model reflects the extreme end of the continuum of ADHD-relevant phenotypes. In short, the SHRs can be viewed as the animal model equivalent of humans with more severe ADHD presentations [7,8], or as a combined ADHD presentation based on DSM categorization. Meanwhile, the Lphn3 KO model represents the lesser extreme of the functional continuum, reflecting a more impulsive presentation, as indicated by the ADHD-relevant phenotypes of hyperactivity [28] and selective aspects of impulsivity [29,31], while preserving automatic attention.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/genes16060672/s1: Tables S1–S14. Summary tables for all inferential statistics comparing Lphn3 KO to WT are presented in Supplementary Tables S1–S7. Summary tables for all inferential statistics comparing SHRs to WKYs are presented in Supplementary Tables S8–S14.

Author Contributions

Conceptualization, L.M.B., J.J.S. and H.J.K.S.; methodology, L.M.B., J.J.S., M.T.W., C.V.V. and H.J.K.S.; software, J.J.S.; validation, J.J.S., L.M.B. and F.A.; formal analysis, L.M.B.; investigation, J.P., L.M.B., J.J.S. and H.J.K.S.; resources, F.A., M.T.W., C.V.V. and H.J.K.S.; data curation, J.P. and L.M.B.; writing—original draft preparation, L.M.B.; writing—review and editing, L.M.B., J.J.S., H.J.K.S., F.A., M.T.W. and C.V.V.; visualization, L.M.B.; supervision, H.J.K.S., J.J.S. and F.A.; funding acquisition, H.J.K.S., F.A., M.T.W. and C.V.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Institute of Environmental Health Sciences under grant number R01ES032270.

Institutional Review Board Statement

All procedures were approved by Institutional Animal Care and Use Committee (IACUC) at the University of Memphis (protocol #0864, active 26 July 2021–25 July 2024) and conducted in accordance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals [57].

Informed Consent Statement

Not applicable.

Data Availability Statement

The dataset analyzed for this project is provided as a Supplementary File.

Acknowledgments

Appreciation is extended to Donny Ray for his assistance with lab animal care and Timothy Mandrell for his veterinary support.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
Adgrl3Adhesion G protein-coupled receptor L3
ADHDAttention-deficit hyperactivity disorder
DADopamine
DATDopamine transporter
EEGElectroencephalography/electroencephalogram
ERPEvent-related potential
ITIInter-train interval
KOKnockout
LCLocus coeruleus
LLAEPLong latency auditory-evoked potential
Lphn3Latrophilin-3
mPFCMedial prefrontal cortex
NAccNucleus accumbens
NENorepinephrine
NETNorepinephrine transporter
WTWildtype
RDoCResearch domain criteria
SHRSpontaneously hypertensive rat
WKYWistar–Kyoto

Appendix A

Appendix A.1. Lphn3 Knockout Rats: Peak-to-Peak Amplitudes

The peak-to-peak amplitudes for each ERP complex, collapsed across sex, are depicted in Figure A1. The P1–N1 peak-to-peak (shown in Figure A1A) demonstrated the anticipated pattern of a larger response to the first tone when preceded by the 5 s ITI (18.50 ± 1.42 µV) compared to the 1 s ITI (9.66 ± 0.81 µV), followed by a decrease in amplitude across tones. A larger P1–N1 was also seen for the second tone following the 5 s ITI compared to the 1 s ITI (p = 0.045); however, this difference was less pronounced (0.84 µV difference; ITI x tone, F (2.419, 84.649) = 64.191, p < 0.001, η p 2 = 0.647). Although a significant interaction of genotype was found (genotype x ITI, F (1, 35) = 4.410, p = 0.043, η p 2 = 0.112), pairwise comparisons did not reveal a significant difference in the P1–N1 between KOs and WTs (p > 0.05). Rather, this effect was driven by the previously robust effect of ITI across both the previously described KO and WT rats (p < 0.001). No significant interactions for genotype or sex were detected.
The N1–P2 peak-to-peak amplitudes (shown in Figure A1B) demonstrated similarities to the P1–N1, wherein the amplitude for the first and second tones was larger after the 5 s ITI (6.92 ± 0.78 µV and 6.10 ± 0.64 µV) compared to the 1 s ITI (4.81 ± 0.48 µV and 4.49 ± 0.46 µV), followed by a gradual reduction across tones. There was also a significant reduction from the first to the third tone only following the longer ITI (2.03 µV difference; ITI x tone, F (2.876, 94.914) = 5.676, p = 0.001, η p 2 = 0.147). Again, no significant effects emerged for genotype or sex.
As shown in Figure A1C, no significant omnibus effects were found for the P2–N2 peak-to-peak amplitudes. The failure to find significant differences in the P2–N2 may have been the result of the pronounced N1 contributing to a reduced P2 in conjunction with a subsequently attenuated N2 peak and decreasing any substantial variation in this response (refer back to Figure 2 in the main text). All peak-to-peak inferential statistics for KOs and WTs are summarized in Supplementary Tables S5–S7.
Figure A1. Peak-to-peak P1–N1 (A), N1–P2 (B), and P2–N2 (C) amplitudes in both Lphn3 KOs and WT controls, not separated by sex, for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Figure A1. Peak-to-peak P1–N1 (A), N1–P2 (B), and P2–N2 (C) amplitudes in both Lphn3 KOs and WT controls, not separated by sex, for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Genes 16 00672 g0a1

Appendix A.2. Lphn3 Knockout Rats: Effect of Sex on Peak Amplitude and Latency

An overall greater reduction in P1 was seen in WT males compared to females (2.01 ± 0.56 µV vs. 3.27 ± 0.62 µV; genotype x sex interaction, F (1, 35) = 5.112, p = 0.030, η p 2 = 0.127). However, this effect did not hold up to pairwise comparisons (p = 0.068), and no other group differences were observed. It also generally peaked earlier in males (51.83 ± 3.28 ms) compared to females (61.37 ± 3.17 ms; main effect of sex, F (1, 35) = 4.369, p = 0.044, η p 2 = 0.111). The N1 peak was significantly earlier to the first tone in males (114.98 ± 4.75 ms) compared to females (129.78 ± 4.60 ms; sex x tone, F (4, 140) = 2.767, p = 0.030, η p 2 = 0.073, but no effect of sex was detected on N1 peak latency. Similarly, while the P2 peaked earlier in females (172.73 ± 11.29 ms) than males (211.17 ± 11.67 ms; main effect of sex, F (1, 35) = 5.607, p = 0.024, η p 2 = 0.138), no effect of sex was seen on the amplitude of the P2. Lastly, larger N2s were generally observed in KO females compared to WT females (−5.58 ± 0.69 µV vs. −3.04 ± 0.76 µV; genotype x sex, F (1, 35) = 4.552, p = 0.040, η p 2 = 0.115. No effects of sex were observed on the peak latency of the N2.

Appendix A.3. Spontaneously Hypertensive Rats: Peak-to-Peak Amplitudes

Peak-to-peak amplitudes for each ERP complex, collapsed across sex, are depicted in Figure A2. The P1–N1 peak-to-peak amplitudes are shown in Figure A2A. The P1–N1 for the first tone were significantly reduced in the SHRs compared to the WKYs following both the 5 s ITI (5.05 ± 0.92 µV vs. 10.91 ± 0.82 µV, respectively) and the 1 s ITI (5.05 ± 0.92 µV vs. 10.91 ± 0.82 µV; strain x ITI x tone, F (2.620, 83.829) = 13.067, p < 0.001, η p 2 = 0.290). Regarding sex, the P1–N1 for the first tone were larger in males than females following the 5 s ITI (9.52 ± 0.87 µV vs. 6.45 ± 0.87 µV, respectively), with no significant difference seen following the 1 s ITI (4.96 ± 0.55 µV vs. 4.18 ± 0.55 µV, respectively; sex x ITI x tone, F (2.620, 83.829) = 4.781, p = 0.006, η p 2 = 0.130). No significant interactions were detected for strain or sex.
The N1–P2 peak-to-peak amplitudes are shown in Figure A2B. Similarly to the P1–N1, the N1–P2 was larger for the first tone following the 5 s ITI (3.68 ± 0.33 µV) compared to the 1 s ITI (2.82 ± 0.23 µV; ITI x tone, F (3.371, 107.882) = 2.927, p = 0.032, η p 2 = 0.084). Regarding strain, the N1–P2 was larger for the first tone in the WKYs compared to the SHRs (3.973 ± 0.35 µV vs. 2.53 ± 0.39 µV, respectively). Furthermore, a reduction in the N1–P2 was observed for the third (1.38 µV difference) and fourth tones (1.75 µV difference) in the WKYs, while this observation was absent in the SHRs (strain x tone, F (2.375, 75.993) = 5.587, p = 0.003, η p 2 = 0.149). No significant effect was observed for sex.
The P2–N2 peak-to-peak amplitudes are shown in Figure A2C. The P2–N2 also demonstrated the expected pattern of a larger response to the first tone following the 5 s ITI (6.86 ± 0.36 µV) compared to the 1 s ITI (5.54 ± 0.38 µV; ITI x tone, F (4, 128) = 5.988, p < 0.001, η p 2 = 0.158). The P2–N2 for the first tone, as well that for the third tone (3.95 ± 0.28 µV vs. 3.34 ± 0.40 µV, respectively; strain x tone, F (4, 128) = 3.601, p = 0.008, η p 2 = 0.101), were larger in the SHRs (7.14 ± 0.47 µV) than in the WKYs (5.26 ± 0.42 µV). Furthermore, despite the notable difference in the P2–N2 amplitudes in the SHRs for the first tone following the 5 s ITI relative to the 1 s ITI (1.92 µV difference, see Figure A2C), no significant interaction was detected (strain x ITI x tone, F (4, 128) = 1.064, p = 0.377, η p 2 = 0.032). No differences were detected with respect to sex. All peak-to-peak inferential statistics for SHRs and WKYs are summarized in Supplemental Tables S12–S14.
Figure A2. Peak-to-peak P1–N1 (A), N1–P2 (B), and P2–N2 (C) amplitudes in both SHRs and WKY controls, not separated by sex, for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Figure A2. Peak-to-peak P1–N1 (A), N1–P2 (B), and P2–N2 (C) amplitudes in both SHRs and WKY controls, not separated by sex, for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Genes 16 00672 g0a2

Appendix A.4. Spontaneously Hypertensive Rats: Effect of Sex on Peak Amplitude and Latency

The P1 for the first tone was larger for males (5.61 ± 0.57 µV) than females (3.25 ± 0.57 µV) when it was preceded by the 5 s ITI (sex x ITI x tone, F (2.824, 90.382) = 3.147, p = 0.032, = 0.090). In addition, while females generally had an earlier-peaking P1 following the 1 s ITI (54.85 ± 5.50 ms) compared to the 5 s ITI (64.60 ± 5.13 ms, sex x ITI interaction, F (1, 32) = 4.525, p = 0.041, η p 2 = 0.124), this effect did not hold in pairwise comparisons (p = 0.070). For the N1, although there was a significant strain x sex x tone interaction [F (3.058, 97.855) = 3.405, p = 0.020, η p 2 = 0.096] with peak amplitude, no meaningful effects or interactions were detected following pairwise comparisons. No significant effect of sex was observed for N1 peak latency. A significant increase in the P2 from the first to the fourth and fifth tones (1.97 µV and 1.65 µV differences, respectively) and from the second to the fourth tone (1.39 µV difference) was observed in the females, while no significant changes were observed in the males across tones (sex x tone, F (3.115, 99.669) = 2.654, p = 0.048, η p 2 = 0.077). No effect of sex on P2 peak latency or N2 peak amplitude or latency was observed.

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Publishing: Washington, DC, USA, 2022. [Google Scholar] [CrossRef]
  2. Danielson, M.L.; Claussen, A.H.; Bitsko, R.H.; Katz, S.M.; Newsome, K.; Blumberg, S.J.; Kogan, M.D.; Reem, G. ADHD prevalence among US children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment. J. Clin. Child Adolesc. Psychol. 2024, 53, 343–360. [Google Scholar] [CrossRef] [PubMed]
  3. Staley, B.S.; Robinson, L.R.; Claussen, A.H.; Katz, S.M.B.; Danielson, M.L.; Summers, A.D.; Farr, S.L.; Blumberg, S.J.; Tinker, S.C. Attention-deficit/hyperactivity disorder diagnosis, Treatment, and telehealth use in adults—National center for health statistics rapid surveys system, United States, October–November 2023. Morb. Mortal. Wkly. Rep. 2014, 73, 890–895. [Google Scholar] [CrossRef] [PubMed]
  4. Faraone, S.V.; Biederman, J.; Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychol. Med. 2006, 36, 159–165. [Google Scholar] [CrossRef]
  5. Luo, Y.; Weibman, D.; Halperin, J.M.; Li, X. A review of heterogeneity in attention deficit/hyperactivity disorder. Front. Hum. Neurosci. 2019, 13, 42. [Google Scholar] [CrossRef]
  6. Faraone, S.V.; Larsson, H. Genetics of attention deficit hyperactivity disorder. Mol. Psychiatry 2019, 24, 562–575. [Google Scholar] [CrossRef]
  7. Faraone, S.V.; Asherson, P.; Banaschewski, T.; Biederman, J.; Buitelaar, J.K.; Ramos-Quiroga, J.A.; Rhode, L.A.; Sonuga-Barke, E.J.S.; Tannock, R.; Franke, B. Attention-deficit/hyperactivity disorder. Nat. Rev. Dis. Primers 2015, 1, 15020. [Google Scholar] [CrossRef]
  8. Faraone, S.V.; Biederman, J. Can attention-deficit/hyperactivity disorder onset occur in adulthood? JAMA Psychiatry 2016, 73, 655–656. [Google Scholar] [CrossRef]
  9. Larsson, H.; Anckarsater, H.; Råstam, M.; Chang, Z.; Lichtenstein, P. Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: A quantitative genetic study of 8500 twin pairs. J. Child Psychol. Psychiatry 2012, 53, 73–80. [Google Scholar] [CrossRef]
  10. Arcos-Burgos, M.; Castellanos, F.X.; Pineda, D.; Lopera, F.; Palacio, J.D.; Palacio, L.G.; Rapoport, J.L.; Berg, K.; Bailey-Wilson, J.E.; Muenke, M. Attention-deficit/hyperactivity disorder in a population isolate: Linkage to loci at 4q13. 2, 5q33. 3, 11q22, and 17p11. Am. J. Hum. Genet. 2004, 75, 998–1014. [Google Scholar] [CrossRef]
  11. Arcos-Burgos, M.; Jain, M.; Acosta, M.T.; Shively, S.; Stanescu, H.; Wallis, D.; Domené, S.; I Vélez, J.; Karkera, J.D.; Balog, J.; et al. A common variant of the latrophilin-3 gene, Lphn3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15, 1053–1066. [Google Scholar] [CrossRef]
  12. Jain, M.; Palacio, L.G.; Castellanos, F.X.; Palacio, J.D.; Pineda, D.; Restrepo, M.I.; Muñoz, J.F.; Lopera, F.; Wallis, D.; Berg, K.; et al. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: Evidence of pleiotropy and new susceptibility loci. Biol. Psychiatry 2007, 61, 1329–1339. [Google Scholar] [CrossRef] [PubMed]
  13. Ribasés, M.; Ramos-Quiroga, J.A.; Sánchez-Mora, C.; Bosch, R.; Richarte, V.; Palomar, G.; Gastaminza, X.; Bielsa, A.; Arcos-Burgos, M.; Muenke, M.; et al. Contribution of Lphn3 to the genetic susceptibility to ADHD in adulthood: A replication study. Genes Brain Behav. 2011, 10, 149–157. [Google Scholar] [CrossRef] [PubMed]
  14. Bruxel, E.M.; Moreira-Maia, C.R.; Akutagava-Martins, G.C.; Quinn, T.P.; Klein, M.; Franke, B.; Ribasés, M.; Rovira, P.; Sánchez-Mora, C.; Kappel, D.B.; et al. Meta-analysis and systematic review of Adgrl3 (Lphn3) polymorphisms in ADHD susceptibility. Mol. Psychiatry 2021, 26, 2277–2285. [Google Scholar] [CrossRef] [PubMed]
  15. Andersson, A.; Tuvblad, C.; Chen, Q.; Du Rietz, E.; Cortese, S.; Kuja-Halkola, R.; Larsson, H. Research Review: The strength of the genetic overlap between ADHD and other psychiatric symptoms—A systematic review and meta-analysis. J. Child Psychol. Psychiatry 2020, 61, 1173–1183. [Google Scholar] [CrossRef]
  16. Cuthbert, B.N. Research domain criteria (RDoC): Progress and potential. Curr. Dir. Psychol. Sci. 2022, 31, 107–114. [Google Scholar] [CrossRef]
  17. Cuthbert, B.N.; Insel, T.R. Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med. 2013, 11, 126. [Google Scholar] [CrossRef]
  18. Iacono, W.G.; Malone, S.M.; Vrieze, S.I. Endophenotype best practices. Int. J. Psychophysiol. 2017, 111, 115–144. [Google Scholar] [CrossRef]
  19. Miller, G.A.; Rockstroh, B. Endophenotypes in psychopathology research: Where do we stand? Annu. Rev. Clin. Psychol. 2013, 9, 177–213. [Google Scholar] [CrossRef]
  20. van der Voet, Á.; Harich, Á.; Franke, Á.; Schenck, A. ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila. Mol. Psychiatry 2016, 21, 565–573. [Google Scholar] [CrossRef]
  21. Fontana, B.D.; Reichmann, F.; Tilley, C.A.; Lavlou, P.; Shkumatava, A.; Alnassar, N.; Hillman, C.; Karlsson, K.A.; Norton, W.H.J.; Parker, M.O. Adgrl3.1-deficient zebrafish show noradrenaline-mediated externalizing behaviors, and altered expression of externalizing disorder-candidate genes, suggesting functional targets for treatment. Transl. Psychiatry 2023, 13, 304. [Google Scholar] [CrossRef]
  22. Lange, M.; Norton, W.; Coolen, M.; Chaminade, M.; Merker, S.; Proft, F.; Schmitt, A.; Vernier, P.; Lesch, K.-P.; Bally-Cuif, L. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol. Psychiatry 2012, 17, 946–954. [Google Scholar] [CrossRef] [PubMed]
  23. Lange, M.; Froc, C.; Grunwald, H.; Norton, W.H.; Bally-Cuif, L. Pharmacological analysis of zebrafish lphn3. 1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2018, 84, 181–189. [Google Scholar] [CrossRef] [PubMed]
  24. Sveinsdóttir, H.S.; Christensen, C.; Þorsteinsson, H.; Lavalou, P.; Parker, M.O.; Shkumatava, A.; Norton, W.H.J.; Andriambeloson, E.; Wagner, S.; Karlsson, K.A. Novel non-stimulants rescue hyperactive phenotype in an Adgrl3.1 mutant zebrafish model of ADHD. Neuropsychopharmacology 2023, 48, 1155–1163. [Google Scholar] [CrossRef] [PubMed]
  25. Mortimer, N.; Ganster, T.; O’Leary, A.; Popp, S.; Freudenberg, F.; Reif, A.; Artigas, M.A.; Ribasés, M.; Ramos-Quiroga, J.A.R.; Lesch, K.; et al. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation. Neuropharmacology 2019, 156, 107557. [Google Scholar] [CrossRef]
  26. Orsini, C.A.; Setlow, B.; DeJesus, M.; Galaviz, S.; Loesch, K.; Ioerger, T.; Wallis, D. Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction. Mol. Genet. Genom. Med. 2016, 4, 322–343. [Google Scholar] [CrossRef]
  27. Wallis, D.; Hill, D.; Mendez, I.A.; Abbott, L.C.; Finnell, R.H.; Wellman, P.J.; Setlow, B. Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. Brain Res. 2012, 1463, 85–92. [Google Scholar] [CrossRef]
  28. Regan, S.L.; Hufgard, J.R.; Pitzer, E.M.; Sugimoto, C.; Hu, Y.C.; Williams, M.T.; Vorhees, C.V. Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers. Neurobiol. Dis. 2019, 130, 104494. [Google Scholar] [CrossRef]
  29. Carbajal, M.S.; Bounmy, A.J.; Harrison, O.B.; Nolen, H.G.; Regan, S.L.; Williams, M.T.; Vorhees, C.V.; Sable, H.J.K. Impulsive choice in two different rat models of ADHD—Spontaneously hypertensive and Lphn3 knockout rats. Front. Neurosci. 2023, 17, 1084218. [Google Scholar] [CrossRef]
  30. González-Barriga, F.; Orduña, V. Spontaneously hypertensive rats show higher impulsive action, but equal impulsive choice with both positive and aversive consequences. Behav. Brain Res. 2022, 427, 113858. [Google Scholar] [CrossRef]
  31. Sable, H.J.; Lester, D.B.; Potter, J.L.; Nolen, H.G.; Cruthird, D.M.; Estes, L.M.; Johnson, A.D.; Regan, S.L.; Vorhees, C.V. An assessment of executive function in two different rat models of attention-deficit hyperactivity disorder: Spontaneously hypertensive versus Lphn3 knockout rats. Genes Brain Behav. 2021, 20, e12767. [Google Scholar] [CrossRef]
  32. Regan, S.L.; Pitzer, E.M.; Hufgard, J.R.; Sugimoto, C.; Williams, M.T.; Vorhees, C.V. A novel role for the ADHD risk gene latrophilin-3 in learning and memory in Lphn3 knockout rats. Neurobiol. Dis. 2021, 158, 105456. [Google Scholar] [CrossRef] [PubMed]
  33. Picton, T.W.; Bentin, S.; Berg, P.; Donchin, E.; Hillyard, S.A.; Johnson, R.; Miller, G.A.; Ritter, W.; Ruchkin, D.S.; Rugg, M.D.; et al. Guidelines for using human event-related potentials to study cognition: Recording standards and publication criteria. Psychophysiology 2000, 37, 127–152. [Google Scholar] [CrossRef] [PubMed]
  34. van Beijsterveldt, C.E.M.; Boomsma, D.I. Genetics of the human electroencephalogram (EEG) and event-related brain potentials (ERPs): A review. Hum. Genet. 1994, 94, 319–330. [Google Scholar] [CrossRef]
  35. Rosen, A.M.; Spellman, T.; Gordon, J.A. Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis. Biol. Psychiatry 2015, 77, 1041–1049. [Google Scholar] [CrossRef]
  36. Modi, M.E.; Sahin, M. Translational use of event-related potentials to assess circuit integrity in ASD. Nat. Rev. Neurol. 2017, 13, 160–170. [Google Scholar] [CrossRef]
  37. Hauser, M.F.; Wiescholleck, V.; Colitti-Klausnitzer, J.; Bellebaum, C.; Manahan-Vaughan, D. Event-related potentials evoked by passive visuospatial perception in rats and humans reveal common denominators in information processing. Brain Struct. Funct. 2019, 224, 1583–1597. [Google Scholar] [CrossRef]
  38. Sambeth, A.; Maes, J.H.; Luijtelaar, G.V.; Molenkamp, I.B.; Jongsma, M.L.; Rijn, C.M. Auditory event-related potentials in humans and rats: Effects of task manipulation. Psychophysiology 2003, 40, 60–68. [Google Scholar] [CrossRef]
  39. Sambeth, A.; Maes, J.H.; Quiroga, R.Q.; Coenen, A.M. Effects of stimulus repetitions on the event-related potential of hummans and rats. Int. J. Psychophysiol. 2004, 53, 197–205. [Google Scholar] [CrossRef]
  40. Pratt, H. Sensory ERP components. In The Oxford Handbook of ERP Components; Luck, S.J., Kappenman, E., Eds.; Oxford University Press: New York, NY, USA, 2012; pp. 98–114. [Google Scholar]
  41. Näätänen, R.; Picton, T. The N1 wave of the human electric and magnetic response to sound: A review and an analysis of the component structure. Psychophysiology 1987, 24, 375–425. [Google Scholar] [CrossRef]
  42. Näätänen, R.; Kujala, T.; Winkler, I. Auditory processing that leads to conscious perception: A unique window to central auditory processing opened by the mismatch negativity and related responses. Psychophysiology 2011, 48, 4–22. [Google Scholar] [CrossRef]
  43. Barry, R.J.; Johnstone, S.J.; Clarke, A.R. A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials. Clin. Neurophysiol. 2003, 114, 184–198. [Google Scholar] [CrossRef] [PubMed]
  44. Johnstone, S.J.; Barry, R.J.; Clarke, A.R. Ten years on: A follow-up review of ERP research in attention-deficit/hyperactivity disorder. Clin. Neurophysiol. 2013, 124, 644–657. [Google Scholar] [CrossRef] [PubMed]
  45. Kaiser, A.; Aggensteiner, P.M.; Baumeister, S.; Holz, N.E.; Banaschewski, T.; Brandeis, D. Earlier versus later cognitive event-related potentials (ERPs) in attention-deficit/hyperactivity disorder (ADHD): A meta-analysis. Neurosci. Biobehav. Rev. 2020, 112, 117–134. [Google Scholar] [CrossRef]
  46. Barry, R.J.; Clarke, A.R.; McCarthy, R.; Selikowitz, M.; Brown, C.R.; Heaven, P.C. Event-related potentials in adults with Attention-Deficit/Hyperactivity Disorder: An investigation using an inter-modal auditory/visual oddball task. Int. J. Psychophysiol. 2009, 71, 124–131. [Google Scholar] [CrossRef]
  47. Prox, V.; Dietrich, D.E.; Zhang, Y.; Emrich, H.M.; Ohlmeier, M.D. Attentional processing in adults with ADHD as reflected by event-related potentials. Neurosci. Lett. 2007, 419, 236–241. [Google Scholar] [CrossRef]
  48. Sable, J.J.; Knopf, K.L.; Kyle, M.R.; Schully, L.T.; Brooks, M.M.; Parry, K.H.; Thompson, I.A.; Suna, E.B.; Stowe, R.; Flink, L.A.; et al. Attention-deficit hyperactivity disorder reduces automatic attention in young adults. Psychophysiology 2013, 50, 308–313. [Google Scholar] [CrossRef]
  49. Budd, T.W.; Nakamura, T.; Fulham, W.R.; Todd, J.; Schall, U.; Hunter, M.; Hodgson, D.M.; Michie, P.T. Repetition suppression of the rat auditory evoked potential at brief stimulus intervals. Brain Res. 2013, 1498, 59–68. [Google Scholar] [CrossRef]
  50. de Bruin, N.M.; Ellenbroek, B.A.; Van Schaijk, W.J.; Cools, A.R.; Coenen, A.M.; Van Luijtelaar, E.L. Sensory gating of auditory evoked potentials in rats: Effects of repetitive stimulation and the interstimulus interval. Biol. Psychol. 2001, 55, 195–213. [Google Scholar] [CrossRef]
  51. Boutros, N.N.; Gjini, K.; Urbach, H.; Pflieger, M.E. Mapping repetition suppression of the N100 evoked response to the human cerebral cortex. Biol. Psychiatry 2011, 69, 883–889. [Google Scholar] [CrossRef]
  52. Okamoto, K.A. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 1963, 27, 282–293. [Google Scholar] [CrossRef]
  53. Regan, S.L.; Williams, M.T.; Vorhees, C.V. Review of rodent models of attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 2022, 132, 621–637. [Google Scholar] [CrossRef] [PubMed]
  54. Sagvolden, T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 2000, 24, 31–39. [Google Scholar] [CrossRef] [PubMed]
  55. Sagvolden, T.; Johansen, E.B.; Wøien, G.; Walaas, S.I.; Storm-Mathisen, J.; Bergersen, L.H.; Hvalby, O.; Jensen, V.; Aase, H.; Russell, V.A.; et al. The spontaneously hypertensive rat model of ADHD–The importance of selecting the approprite reference strain. Neuropharmacology 2009, 57, 619–626. [Google Scholar] [CrossRef]
  56. Moridera, A.; Shinba, T.; Yoshi, M.; Inoue, M.; Azuma, K.; Saka, N.; Kubo, H.; Mugishima, G. Auditory event-related potentials to paired stimulation in spontaneously hypertensive rat (SHR) show difference of undulation: Relation to dysfunction of sensory gating in an animal model of attention deficit hyperactivity disorder (ADHD). Jpn. J. Physiol. Psychol. Psychophysiol. 2020, 38, 4–11. [Google Scholar] [CrossRef]
  57. NIH. Public Health Service Policy on Humane Care and Use of Laboratory Animals; NIH: Bethesda, MD, USA, 2015. [Google Scholar]
  58. Brewer, L.M.; Holdford, M.M.; Holloway, Z.R.; Sable, J.J.; Andrasik, F.; Sable, H.J.K. Isoflurane effects on the N1 and other long-latency auditory evoked potentials in Wistar rats. Neurosci. Res. 2021, 173, 71–79. [Google Scholar] [CrossRef]
  59. Faul, F.; Erdfelder, E.; Lang, A.-G.; Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39, 175–191. [Google Scholar] [CrossRef]
  60. Fabiani, M.; Low, K.A.; Wee, E.; Sable, J.J.; Gratton, G. Reduced suppression or labile memory? Mechanisms of inefficient filtering of irrelevant information in older adults. J. Cogn. Neurosci. 2006, 18, 637–650. [Google Scholar] [CrossRef]
  61. Sable, J.J.; Low, K.A.; Maclin, E.L.; Fabiani, M. Latent inhibition mediates N1 attenuation to repeating sounds. Psychophysiology 2004, 41, 636–642. [Google Scholar] [CrossRef]
  62. Posner, M.I.; Petersen, S.E. The attention system of the human brain. Annu. Rev. Neurosci. 1990, 13, 25–42. [Google Scholar] [CrossRef]
  63. Petersen, S.E.; Posner, M.I. The attention system of the human brain: 20 years after. Annu. Rev. Neurosci. 2012, 35, 73–89. [Google Scholar] [CrossRef]
  64. Johnson, K.A.; Robertson, I.H.; Barry, E.; Mulligan, A.; Dáibhis, A.; Daly, M.; Watchorn, A.; Gill, M.; Bellgrove, M.A. Impaired conflict resolution and alerting in children with ADHD: Evidence from the Attention Network Task (ANT). J. Child Psychol. Psychiatry 2008, 49, 1339–1347. [Google Scholar] [CrossRef] [PubMed]
  65. Maness, E.B.; Burk, J.A.; McKenna, J.T.; Schiffino, F.L.; Strecker, R.E.; McCoy, J.G. Role of the locus coeruleus and basal forebrain in arousal and attention. Brain Res. Bull. 2022, 188, 47–58. [Google Scholar] [CrossRef] [PubMed]
  66. Halperin, J.M.; Schulz, K.P. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychol. Bull. 2006, 132, 560. [Google Scholar] [CrossRef] [PubMed]
  67. Aston-Jones, G.; Rajkowski, J.; Cohen, J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog. Brain Res. 2000, 126, 165–182. [Google Scholar] [CrossRef] [PubMed]
  68. Chandler, D.J.; Gao, W.J.; Waterhouse, B.D. Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices. Proc. Natl. Acad. Sci. USA 2014, 111, 6816–6821. [Google Scholar] [CrossRef]
  69. Berridge, C.W.; Waterhouse, B.D. The locus coeruleus–noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res. Rev. 2003, 42, 33–84. [Google Scholar] [CrossRef]
  70. Sara, S.J. The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci. 2009, 10, 211–223. [Google Scholar] [CrossRef]
  71. Sara, S.J.; Bouret, S. Orienting and reorienting: The locus coeruleus mediates cognition through arousal. Neuron 2012, 76, 130–141. [Google Scholar] [CrossRef]
  72. Waterhouse, B.D.; Navarra, R.L. The locus coeruleus-norepinephrine system and sensory signal processing: A historical review and current perspectives. Brain Res. 2019, 1709, 1–15. [Google Scholar] [CrossRef]
  73. Aston-Jones, G.; Cohen, J.D. Adaptive gain and the role of the locus coeruleus–norepinephrine system in optimal performance. J. Comp. Neurol. 2005, 493, 99–110. [Google Scholar] [CrossRef]
  74. Vazey, E.M.; Moorman, D.E.; Aston-Jones, G. Phasic locus coeruleus activity regulates cortical encoding of salience information. Proc. Natl. Acad. Sci. USA 2018, 115, E9439–E9448. [Google Scholar] [CrossRef] [PubMed]
  75. Aston-Jones, G.; Iba, M.; Clayton, E.; Rajkowski, J.; Cohen, J. The locus coeruleus and regulation of behavioral flexibility and attention: Clinical implications. In Brain Norepinephrine: Neurobiology and Therapeutics; Ordway, G.A., Schwartz, M.A., Frazer, A., Eds.; Cambridge University Press: Cambridge, UK, 2007; pp. 196–235. [Google Scholar] [CrossRef]
  76. Aboitiz, F.; Ossandón, T.; Zamorano, F.; Palma, B.; Carrasco, X. Irrelevant stimulus processing in ADHD: Catecholamine dynamics and attentional networks. Front. Psychol. 2014, 5, 60632. [Google Scholar] [CrossRef] [PubMed]
  77. Sergeant, J. The cognitive-energetic model: An empirical approach to attention-deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 2000, 24, 7–12. [Google Scholar] [CrossRef]
  78. Sergeant, J. Modeling attention-deficit/hyperactivity disorder: A critical appraisal of the cognitive-energetic model. Biol. Psychiatry 2005, 57, 1248–1255. [Google Scholar] [CrossRef]
  79. Sanders, A. Towards a model of stress and human performance. Acta Psychol. 1983, 53, 61–97. [Google Scholar] [CrossRef]
  80. de Villiers, A.S.; Russell, V.A.; Sagvolden, T.; Searson, A.; Jaffer, A.; Taljaard, J.J. β 2 Mediated inhibition of [3H] dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem. Res. 1995, 20, 427–433. [Google Scholar] [CrossRef]
  81. Russell, V.A. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder—The spontaneously hypertensive rat. Behav. Brain Res. 2002, 130, 191–196. [Google Scholar] [CrossRef]
  82. Igata, S.; Hayashi, T.; Itoh, M.; Akasu, T.; Takano, M.; Ishimatsu, M. Persistent α1-adrenergic receptor function in the nucleus locus coeruleus causes hyperexcitability in AD/HD model rats. J. Neurophysiol. 2014, 111, 777–786. [Google Scholar] [CrossRef]
  83. Qi RLi, M.; Ma, Y.; Chen, N. State-dependent changes in auditory sensory gating in different cortical areas in rats. PLoS ONE 2015, 10, e0126684. [Google Scholar] [CrossRef]
  84. Rajkowski, J.; Kubiak, P.; Aston-Jones, G. Locus coeruleus activity in monkey: Phasic and tonic changes are associated with altered vigilance. Brain Res. Bull. 1994, 35, 607–616. [Google Scholar] [CrossRef]
  85. Yang, M.; Logothetis, N.K.; Eschenko, O. Phasic activation of the locus coeruleus attenuates the acoustic startle response by increasing cortical arousal. Sci. Rep. 2021, 11, 1409. [Google Scholar] [CrossRef] [PubMed]
  86. Ichtchenko, K.; Bittner, M.A.; Krasnoperov, V.; Little, A.R.; Chepurny, O.; Holz, R.W.; Petrenko, A.G. A novel ubiquitously expressed α-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors. J. Biol. Chem. 1999, 274, 5491–5498. [Google Scholar] [CrossRef] [PubMed]
  87. Sugita, S.; Ichtchenko, K.; Khvotchev, M.; Südhof, T.C. α-Latrotoxin receptor CIRL/latrophilin 1 (CL1) defines an unusual family of ubiquitous G-protein-linked receptors: G-protein coupling not required for triggering exocytosis. J. Biol. Chem. 1998, 273, 32715–32724. [Google Scholar] [CrossRef] [PubMed]
  88. Martinez, A.F.; Muenke, M.; Arcos-Burgos, M. From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2010, 156, 1–10. [Google Scholar] [CrossRef]
  89. Moreno-Salinas, A.L.; Avila-Zozaya, M.; Ugalde-Silva, P.; Hernández-Guzmán, D.A.; Missirlis, F.; Boucard, A.A. Latrophilins: A neuro-centric view of an evolutionary conserved adhesion G protein-coupled receptor subfamily. Front. Neurosci. 2019, 13, 465743. [Google Scholar] [CrossRef]
  90. Sando, R.; Jiang, X.; Südhof, T.C. Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins. Science 2019, 363, eaav7969. [Google Scholar] [CrossRef]
  91. Regan, S.L.; Cryan, M.T.; Williams, M.T.; Vorhees, C.V.; Ross, A.E. Enhanced transient striatal dopamine release and reuptake in Lphn3 knockout rats. ACS Chem. Neurosci. 2020, 11, 1171–1177. [Google Scholar] [CrossRef]
  92. Sable, H.J.; Paige, N.B.; Nalan, P.A.; Pace, R.L.; Hicks, C.B.; Regan, S.L.; Williams, M.T.; Vorhees, C.V.; Lester, D.B. Phasic dopamine release in two different rat models of attention-deficit/hyperactivity disorder: Spontaneously hypertensive rats (SHR) versus Lphn3 knockout rats. Neuroscience 2025, 567, 150–162. [Google Scholar] [CrossRef]
  93. Tachibana, M.; Yamamichi, I.; Nakae, S.; Hirasugi, Y.M.; Mizukoshi, O. The site of involvement of hypertension within the cochlea: A comparative study of normotensive and spontaneously hypertensive rats. Acta Oto-Laryngol. 1984, 97, 257–265. [Google Scholar] [CrossRef]
  94. Sui, L.; Shusheng, G.; Yanzhen, Y.; Qingsong, Y. Effect of hypertension on hearing function, LDH and ChE of the cochlea in older rats. Curr. Med. Sci. 2003, 23, 306–309. [Google Scholar] [CrossRef]
  95. Brace, L.R.; Kraev, I.; Rostron, C.L.; Stewart, M.G.; Overton, P.G.; Dommett, E.J. Auditory responses in a rodent model of attention deficit hyperactivity disorder. Brain Res. 2015, 1629, 10–25. [Google Scholar] [CrossRef] [PubMed]
  96. Simpson, G.V.; Knight, R.T. Multiple brain systems generating the rat auditory evoked potential. II. Dissociation of auditory cortex and non-lemniscal generator systems. Brain Res. 1993, 602, 251–262. [Google Scholar] [CrossRef]
  97. Russell, W.M.; Burch, R.L. The Principles of Humane Experimental Technique; Universities Federation for Animal Welfare: St Albans, UK, 1959. [Google Scholar]
  98. ThiNational Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. 13 September 2019. Available online: https://www.nice.org.uk/guidance/ng87 (accessed on 23 May 2025).
  99. Madras, B.K.; Miller, G.M.; Fischman, A.J. The dopamine transporter and attention deficit/hyperactivity disorder. Biol. Psychiatry 2005, 57, 1397–1409. [Google Scholar] [CrossRef] [PubMed]
  100. Leffa, D.T.; Panzenhagen, A.C.; Salvi, A.A.; Bau, C.H.; Pires, G.N.; Torres, I.L.; Rohde, L.A.; Rovaris, D.L.; Grevet, E.H. Systematic review and meta-analysis of the behavioral effects of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Neurosci. Biobehav. Rev. 2019, 100, 166–179. [Google Scholar] [CrossRef]
  101. Dommett, E.J. Using the five-choice serial reaction time task to examine the effects of atomoxetine and methylphenidate in the male spontaneously hypertensive rat. Pharmacol. Biochem. Behav. 2014, 124, 196–203. [Google Scholar] [CrossRef]
  102. Turner, M.; Wilding, E.; Cassidy, E.; Dommett, E.J. Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat. Behav. Brain Res. 2013, 243, 28–37. [Google Scholar] [CrossRef]
Figure 1. Outline of 5-tone train paradigm. Trains were separated randomly by either 1 or 5 s of silence (offset to onset). Each rat was presented with 320 tone trains, with 160 being preceded by a 1 s ITI (i.e., short) or a 5 s ITI (long). Tones were 50 ms in duration with a 400 ms SOA.
Figure 1. Outline of 5-tone train paradigm. Trains were separated randomly by either 1 or 5 s of silence (offset to onset). Each rat was presented with 320 tone trains, with 160 being preceded by a 1 s ITI (i.e., short) or a 5 s ITI (long). Tones were 50 ms in duration with a 400 ms SOA.
Genes 16 00672 g001
Figure 2. Average ERP waveforms for KOs and WTs to 5-tone trains following both the 5 s (i.e., long) and 1 s (i.e., short) ITIs. Black hollow rectangles indicate the presentation of each 50 ms tone in the train.
Figure 2. Average ERP waveforms for KOs and WTs to 5-tone trains following both the 5 s (i.e., long) and 1 s (i.e., short) ITIs. Black hollow rectangles indicate the presentation of each 50 ms tone in the train.
Genes 16 00672 g002
Figure 3. Peak amplitudes of P1 (A), N1 (B), P2 (C), and N2 (D) for both Lphn3 KOs and WT controls not separated by sex for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Figure 3. Peak amplitudes of P1 (A), N1 (B), P2 (C), and N2 (D) for both Lphn3 KOs and WT controls not separated by sex for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Genes 16 00672 g003
Figure 4. Average ERP waveforms for SHRs and WKYs to a 5-tone train following both the 5 s (i.e., long) and 1 s (i.e., short) ITIs. Black hollow rectangles indicate the presentation of each 50 ms tone in the tone train.
Figure 4. Average ERP waveforms for SHRs and WKYs to a 5-tone train following both the 5 s (i.e., long) and 1 s (i.e., short) ITIs. Black hollow rectangles indicate the presentation of each 50 ms tone in the tone train.
Genes 16 00672 g004
Figure 5. Peak amplitudes of P1 (A), N1 (B), P2 (C), and N2 (D) for both SHRs and WKY controls, not separated by sex, for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Figure 5. Peak amplitudes of P1 (A), N1 (B), P2 (C), and N2 (D) for both SHRs and WKY controls, not separated by sex, for both 1 s and 5 s (long) ITIs. Error bars represent the standard error of the mean (SEM).
Genes 16 00672 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Brewer, L.M.; Patel, J.; Andrasik, F.; Sable, J.J.; Williams, M.T.; Vorhees, C.V.; Sable, H.J.K. Auditory Event-Related Potentials in Two Rat Models of Attention-Deficit Hyperactivity Disorder: Evidence of Automatic Attention Deficits in Spontaneously Hypertensive Rats but Not in Latrophilin-3 Knockout Rats. Genes 2025, 16, 672. https://doi.org/10.3390/genes16060672

AMA Style

Brewer LM, Patel J, Andrasik F, Sable JJ, Williams MT, Vorhees CV, Sable HJK. Auditory Event-Related Potentials in Two Rat Models of Attention-Deficit Hyperactivity Disorder: Evidence of Automatic Attention Deficits in Spontaneously Hypertensive Rats but Not in Latrophilin-3 Knockout Rats. Genes. 2025; 16(6):672. https://doi.org/10.3390/genes16060672

Chicago/Turabian Style

Brewer, Logan M., Jankiben Patel, Frank Andrasik, Jeffrey J. Sable, Michael T. Williams, Charles V. Vorhees, and Helen J. K. Sable. 2025. "Auditory Event-Related Potentials in Two Rat Models of Attention-Deficit Hyperactivity Disorder: Evidence of Automatic Attention Deficits in Spontaneously Hypertensive Rats but Not in Latrophilin-3 Knockout Rats" Genes 16, no. 6: 672. https://doi.org/10.3390/genes16060672

APA Style

Brewer, L. M., Patel, J., Andrasik, F., Sable, J. J., Williams, M. T., Vorhees, C. V., & Sable, H. J. K. (2025). Auditory Event-Related Potentials in Two Rat Models of Attention-Deficit Hyperactivity Disorder: Evidence of Automatic Attention Deficits in Spontaneously Hypertensive Rats but Not in Latrophilin-3 Knockout Rats. Genes, 16(6), 672. https://doi.org/10.3390/genes16060672

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop